Personal View

Consent forms for clinical trials are too aggressive

BMJ 2013; 347 doi: http://dx.doi.org/10.1136/bmj.f4879 (Published 13 August 2013)
Cite this as: BMJ 2013;347:f4879

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Richard J Wassersug, adjunct professor, psycho-oncology, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
  1. richard.wassersug{at}ubc.ca

Patients may be put off enrolling in studies by the language used in informed consent forms, and insisted on by ethics committees, says patient and researcher Richard J Wassersug

I have the privilege of being a cancer patient as well as a cancer researcher. So I have looked at informed consent forms for clinical trials from both sides of the fence. But it wasn’t until I had to produce one for my own research that I began to understand why every consent form that I had read as a patient had made me uncomfortable. It wasn’t anything about the study itself that bothered me—it was the language used in the forms.

I had assumed that the researchers simply didn’t know how to write a document that was reader friendly, but then I found out that my own university’s institutional review board actually required me to write in that same unfriendly manner.

What I have learnt from having to design consent forms for my own clinical trials is that two contradictory principles drive their language. One says …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL